Evidence map›Paper›PMID 31035604›Full record

ArticleJournal of clinical medicine2019

Relevance of Targeting the Distal Renal Artery and Branches with Radiofrequency Renal Denervation Approaches-A Secondary Analysis from a Hypertensive CKD Patient Cohort.

Márcio Galindo Kiuchi, Markus P Schlaich, Shaojie Chen, Humberto Villacorta, Jan K Ho, Revathy Carnagarin, Vance B Matthews, Jocemir Ronaldo Lugon

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Multi-Organ Denervation: The Past, Present and Future.Journal of clinical medicine · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Autonomic Nervous System: From Bench to Bedside.Journal of clinical medicine · 2020
    Article
  6. Recent advances in the management of secondary hypertension: chronic kidney disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Márcio Galindo KiuchiDobney Hypertension Cenre, School of Medicine-Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000, MDBP: M570, Australia. marcio.galindokiuchi@uwa.edu.au.
Markus P SchlaichDobney Hypertension Cenre, School of Medicine-Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000, MDBP: M570, Australia. markus.schlaich@uwa.edu.au.
Shaojie ChenCardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Frankfurt am Main 60431, Germany. jan.ho@uwa.edu.au.
Humberto VillacortaCardiology Division, Department of Medicine, Universidade Federal Fluminense, Niterói, RJ 24033-900, Brazil. revathy.carnagarin@uwa.edu.au.
Jan K HoDobney Hypertension Cenre, School of Medicine-Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000, MDBP: M570, Australia. vance.matthews@uwa.edu.au.
Revathy CarnagarinDobney Hypertension Cenre, School of Medicine-Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000, MDBP: M570, Australia. shaojie.chen@hotmail.com.
Vance B MatthewsDobney Hypertension Cenre, School of Medicine-Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000, MDBP: M570, Australia. huvillacorta@globo.com.
Jocemir Ronaldo LugonNephrology Division, Department of Medicine, Universidade Federal Fluminense, Niterói, RJ 24033-900, Brazil. jrlugon@id.uff.br.
The University of Western Australia · AUUniversidade Federal Fluminense · BRAgaplesion Bethanien Krankenhaus · DEBaker Heart and Diabetes Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We searched for an association between changes in blood pressure (BP) at 12 and 24 months after renal denervation (RDN) and the different patterns of ablation spots placement along the renal artery vasculature. We performed a post-hoc analysis of a 24-month follow-up evaluation of 30 patients who underwent RDN between 2011 and 2012 using our previous database. Patients who had (i) resistant hypertension, as meticulously described previously, and (ii) Chronic kidney disease (CKD) stages 2, 3 and 4. Correlations were assessed using the Pearson or Spearman correlation tests as appropriate. The mean change in systolic ambulatory BP monitoring (ABPM) compared to baseline was -19.4 ± 12.7 mmHg at the 12th (p < 0.0001) and -21.3 ± 14.1 mmHg at the 24th month (p < 0.0001). There was no correlation between the ABPM Systolic Blood Pressure (SBP)-lowering effect and the total number of ablated spots in renal arteries (17.7 ± 6.0) either at 12 (r = -0.3, p = 0.1542) or at 24 months (r = -0.2, p = 0.4009). However, correlations between systolic BP-lowering effect and the number of ablation spots performed in the distal segment and branches were significant at the 12 (r = -0.7, p < 0.0001) and 24 months (r = -0.8, p < 0.0001) follow-up. Our findings indicate a substantial correlation between the numbers of ablated sites in the distal segment and branches of renal arteries and the systolic BP-lowering effect in the long-term.

Indexed as

blood pressure reductionchronic kidney diseasehypertensionrenal denervationsympathetic nervous system

Identifiers

PMID31035604
PMCPMC6572309
OpenAlexW2942361603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.